How many studies have been conducted on Angiotensin Ii?

BiohacksAI has indexed 300 PubMed studies on Angiotensin Ii, including 5 randomized controlled trials (RCTs). 11% of studies involve human subjects.

What are the main research areas for Angiotensin Ii?

The primary research domains for Angiotensin Ii are ❤️ Cardiovascular, 🫘 Kidney, 🧠 Focus & Attention. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

Angiotensin Ii

An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS.

300+ PubMed studies analyzed · 5 RCTs · Evidence Score: 45.7

Research Domains

Angiotensin Ii has been studied across 19 research domains including ❤️ Cardiovascular, 🫘 Kidney, 🧠 Focus & Attention, 🦴 Bone & Joint, 🔬 Inflammation. The primary research focus is ❤️ Cardiovascular with 29% of studies addressing this area.

Loading evidence profile...

This evidence profile for Angiotensin Ii is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.